Oncological outcomes of planned and unplanned low Hartmann’s procedure and restorative low anterior resection for rectal cancer: a population-based cross-sectional study - Scorecard - MDSpire

Oncological outcomes of planned and unplanned low Hartmann’s procedure and restorative low anterior resection for rectal cancer: a population-based cross-sectional study

  • By

  • E. G. M. van Geffen

  • F. S. Verheij

  • S. M. J. A. Hazen

  • T. C. Sluckin

  • E. C. J. Consten

  • J.-W. T. Dekker

  • J. Nederend

  • K. C. M. J. Peeters

  • J. H. W. de Wilt

  • S. van Dieren

  • R. Hompes

  • J. B. Tuynman

  • C. A. M. Marijnen

  • P. J. Tanis

  • M. Kusters

  • November 23, 2025

  • 0 min

Share

Clinical Scorecard: Comparative Analysis of Oncological Outcomes in Intentional versus Unintentional Low Hartmann’s Procedure and Restorative Low Anterior Resection for Rectal Cancer

At a Glance

CategoryDetail
ConditionRectal cancer requiring total mesorectal excision (TME)
Key MechanismsSurgical approach (restorative low anterior resection vs low Hartmann’s procedure) influences oncological outcomes; tumor location and intraoperative factors affect procedure choice
Target PopulationPatients undergoing curative resection for primary rectal cancer
Care SettingSurgical oncology in hospital settings with multidisciplinary teams

Key Highlights

  • Low Hartmann’s procedure (low-HP) is performed either intentionally preoperatively or unplanned intraoperatively due to technical difficulties.
  • Low-HP is associated with worse oncological outcomes including higher circumferential margin positivity and increased local recurrence rates compared to restorative low anterior resection (rLAR).
  • Patient factors such as narrow pelvis, obesity, bulky distal tumor, comorbidities, and neoadjuvant irradiation influence the likelihood of unplanned low-HP.

Guideline-Based Recommendations

Diagnosis

  • Use tumor location relative to anorectal junction to guide surgical planning.
  • Assess tumor stage and risk factors per Dutch national guidelines to determine neoadjuvant treatment.

Management

  • Perform restorative low anterior resection (rLAR) with anastomosis when feasible for sphincter preservation.
  • Consider low Hartmann’s procedure (low-HP) when poor functional outcome or high risk of anastomotic leakage is anticipated.
  • Inform patients preoperatively about the possibility of intraoperative conversion from rLAR to low-HP.

Monitoring & Follow-up

  • Monitor for local recurrence over at least 4 years postoperatively.
  • Evaluate for metachronous distant metastases after 3 months post-surgery.
  • Assess for pelvic sepsis including anastomotic leakage and presacral abscess.

Risks

  • Higher risk of positive circumferential resection margin and local recurrence with low-HP.
  • Increased risk of pelvic sepsis and complications related to anastomotic leakage.
  • Potential for worse disease-free and overall survival in patients undergoing low-HP.

Patient & Prescribing Data

Patients undergoing curative rectal cancer surgery with either rLAR or low-HP

Patients planned for low-HP often have higher age, more comorbidities, and prior neoadjuvant irradiation; unplanned low-HP is linked to intraoperative technical challenges.

Clinical Best Practices

  • Preoperative multidisciplinary evaluation to select optimal surgical approach based on tumor location and patient factors.
  • Counsel patients regarding risks and potential intraoperative changes in surgical plan.
  • Aim for restorative low anterior resection when feasible to improve oncological outcomes.
  • Recognize and manage intraoperative factors that may necessitate conversion to low-HP.
  • Ensure long-term follow-up for local recurrence and distant metastases.

References

Original Source(s)

Related Content